Cargando…

Honokiol is a FOXM1 antagonist

Honokiol is a natural product and an emerging drug for a wide variety of malignancies, including hematopoietic malignancies, sarcomas, and common epithelial tumors. The broad range of activity of honokiol against numerous malignancies with diverse genetic backgrounds suggests that honokiol is inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halasi, Marianna, Hitchinson, Ben, Shah, Binal N., Váraljai, Renáta, Khan, Irum, Benevolenskaya, Elizaveta V., Gaponenko, Vadim, Arbiser, Jack L., Gartel, Andrei L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833612/ https://www.ncbi.nlm.nih.gov/pubmed/29367668 http://dx.doi.org/10.1038/s41419-017-0156-7

Ejemplares similares

Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells
por: Chesnokov, Mikhail S., et al.
Publicado: (2021)

FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML
por: Chesnokov, Mikhail S, et al.
Publicado: (2021)

Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-Damage
por: Halasi, Marianna, et al.
Publicado: (2012)

FoxM1 Is a General Target for Proteasome Inhibitors
por: Bhat, Uppoor G., et al.
Publicado: (2009)

Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
por: Bhat, Uppoor G., et al.
Publicado: (2009)

FOXM1 contributes to treatment failure in acute myeloid leukemia
por: Khan, Irum, et al.
Publicado: (2018)

The antagonistic duality of NPM1 mutations in AML
por: Khan, Irum, et al.
Publicado: (2022)

The oncogenic transcription factor FOXM1 and anticancer therapy
por: Gartel, Andrei L.
Publicado: (2012)

Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors
por: Gartel, Andrei L.
Publicado: (2014)

Mutual Regulation of FOXM1, NPM and ARF Proteins
por: Pandit, Bulbul, et al.
Publicado: (2015)

Thiazole Antibiotics Siomycin a and Thiostrepton Inhibit the Transcriptional Activity of FOXM1
por: Gartel, Andrei L.
Publicado: (2013)

Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo
por: Bonner, Michael Y., et al.
Publicado: (2016)

The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA
por: Wang, Ming, et al.
Publicado: (2011)

Increased mitochondrial function downstream from KDM5A histone demethylase rescues differentiation in pRB-deficient cells
por: Váraljai, Renáta, et al.
Publicado: (2015)

Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies
por: Mędra, Aleksandra, et al.
Publicado: (2016)

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis
por: Nagalingam, Arumugam, et al.
Publicado: (2012)

Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer
por: Avtanski, Dimiter B., et al.
Publicado: (2015)

Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
por: Salgado-Benvindo, Clarisse, et al.
Publicado: (2023)

Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis
por: Nagalingam, Arumugam, et al.
Publicado: (2017)

Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial SIRT3
por: Pillai, Vinodkumar B., et al.
Publicado: (2015)

NMR resonance assignment and structure prediction of the C-terminal domain of the microtubule end-binding protein 3
por: Abdelkarim, Hazem, et al.
Publicado: (2020)

Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment
por: Muniraj, Nethaji, et al.
Publicado: (2020)

Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol
por: Zang, Hongjing, et al.
Publicado: (2020)

Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice
por: Pillai, Vinodkumar B., et al.
Publicado: (2017)

Honokiol Enhances Paclitaxel Efficacy in Multi-Drug Resistant Human Cancer Model through the Induction of Apoptosis
por: Wang, Xu, et al.
Publicado: (2014)

Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner
por: Avtanski, Dimiter B., et al.
Publicado: (2015)

Favorable outcomes of NPM1(mut) AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance
por: Khan, I., et al.
Publicado: (2023)

Honokiol Prevents Non-Alcoholic Steatohepatitis-Induced Liver Cancer via EGFR Degradation through the Glucocorticoid Receptor—MIG6 Axis
por: Okuda, Keiichiro, et al.
Publicado: (2021)

Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells
por: Kataoka, Seita, et al.
Publicado: (2021)

Antineoplastic Effects of Honokiol on Melanoma
por: Guillermo-Lagae, Ruth, et al.
Publicado: (2017)

The application prospects of honokiol in dermatology
por: Li, Yao, et al.
Publicado: (2022)

Found in transcription: FOXO1 upregulates miRNAs on chromosome X
por: Gartel, Andrei L
Publicado: (2013)

Honokiol blocks store operated calcium entry in CHO cells expressing the M3 muscarinic receptor: honokiol and muscarinic signaling
por: Wang, Hsiu-Jen, et al.
Publicado: (2013)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Honokiol and Magnolol: Insights into Their Antidermatophytic Effects
por: Trifan, Adriana, et al.
Publicado: (2021)

Honokiol as a specific collagen receptor glycoprotein VI antagonist on human platelets: Functional ex vivo and in vivo studies
por: Lee, Tzu-Yin, et al.
Publicado: (2017)

Thiazole Antibiotic Thiostrepton Synergize with Bortezomib to Induce Apoptosis in Cancer Cells
por: Pandit, Bulbul, et al.
Publicado: (2011)

Development of tolerance to chemokine receptor antagonists: current paradigms and the need for further investigation
por: Grudzien, Patrick, et al.
Publicado: (2023)

Neuro-Modulating Effects of Honokiol: A Review
por: Woodbury, Anna, et al.
Publicado: (2013)

Honokiol Improves Liver Steatosis in Ovariectomized Mice
por: Jeong, Yeon-Hui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tt9vm9u9jhtdrm30jf80kd0u9m